Based on the expressions of receptors, BC is categorized as Luminal A (ER positive and/or PR positive and HER2 negative), Luminal B (ER positive and/or PR positive and HER2 negative or positive), HER2+ (ER and PR negative, HER2 positive) and triple-negative breast cancer (ER/PR/HER2 negative). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.